Bicara Therapeutics Inc.
Ownership
Ownership Structure
Who owns Bicara Therapeutics Inc. (BCAX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 55.8% of the shares are freely tradable; institutional investors hold 104.3%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RA Capital Management, LLC | 10.97 | 7,255,993 | +4.3 | 03/31/2026 |
| T. Rowe Price Investment Management,Inc. | 9.98 | 6,605,780 | +94.2 | 03/31/2026 |
| Siren, L.L.C. | 8.77 | 5,802,970 | +11.2 | 03/31/2026 |
| Vestal Point Capital LP | 8.20 | 5,425,000 | +51.7 | 03/31/2026 |
| Deep Track Capital, LP | 6.20 | 4,100,000 | +0.9 | 06/30/2026 |
| HHG PLC | 5.05 | 3,339,218 | +26.2 | 03/31/2026 |
| Red Tree Management, LLC | 4.78 | 3,163,517 | -0.2 | 06/30/2026 |
| TPG GP A, LLC | 4.55 | 3,010,425 | +0.0 | 03/31/2026 |
| BlackRock Inc | 4.30 | 2,843,707 | +12.5 | 03/31/2026 |
| Omega Fund Management LLC | 3.62 | 2,392,150 | +8.5 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Mazumdar Claire | Chief Executive Officer | 362,152 | 8,184,635 $ | Aug 10, 2026 | direct |
| Cohlhepp Ryan | President, COO & Interim CEO | 181,641 | 4,105,087 $ | Sep 8, 2026 | direct |
| Hyep Ivan | Chief Financial Officer | 129,855 | 2,934,723 $ | Aug 10, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Cohlhepp Ryan | President, COO & Interim CEO | Sell | 3,442 | 23.43 | 80,663 |
| Sep 8, 2026 | Cohlhepp Ryan | President, COO & Interim CEO | Sell | 14,058 | 22.77 | 320,053 |
| Sep 8, 2026 | Cohlhepp Ryan | President, COO & Interim CEO | Other | 17,500 | 3.79 | 66,322 |
| Aug 10, 2026 | Hyep Ivan | Chief Financial Officer | Sell | 12,500 | 27.97 | 349,591 |
| Aug 10, 2026 | Hyep Ivan | Chief Financial Officer | Other | 12,500 | 3.79 | 47,373 |
| Aug 10, 2026 | Mazumdar Claire | Chief Executive Officer | Sell | 10,000 | 27.98 | 279,750 |
| Aug 10, 2026 | Mazumdar Claire | Chief Executive Officer | Other | 10,000 | 3.79 | 37,898 |
| Aug 10, 2026 | Cohlhepp Ryan | President and COO | Sell | 18,750 | 27.98 | 524,533 |
| Aug 10, 2026 | Cohlhepp Ryan | President and COO | Other | 18,750 | 3.79 | 71,059 |
| Jul 10, 2026 | Mazumdar Claire | Chief Executive Officer | Sell | 28 | 29.68 | 831 |
| Jul 10, 2026 | Mazumdar Claire | Chief Executive Officer | Sell | 9,972 | 28.42 | 283,367 |
| Jul 10, 2026 | Mazumdar Claire | Chief Executive Officer | Other | 10,000 | 3.79 | 37,898 |
| Apr 21, 2026 | Ivan Hyep | CFO | Sell | 9,200 | 23.00 | 211,600 |
| Apr 20, 2026 | Claire Mazumdar | CEO | Sell | 15,000 | 23.61 | 354,150 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.